PFE
NYSE Pfizer Inc.$28.28 ↑ +0.00 (+0.00%) Trading Up from the previous close of $28.28, and at the day’s high of $28.29
- YTD change
- +13.57%
- vs 20-day SMA
- +1.13%
- vs 200-day SMA
- +6.92%
Price ranges
Price & Performance
+1.06 (+3.89%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 54.2% away from all-time highs of $61.71
- PFE is up 14% since the beginning of the year
- PFE is up 12% over the past 12 months
- PFE is up 2% over the past 1 month
- 3% of all PFE investors are betting against PFE
- Number of investors short PFE has gone up 2% versus last month
PFE reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +12.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +0.57%
- vs 8-day SMA
- +1.05%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
